224 related articles for article (PubMed ID: 26202347)
1. Addiction to MTH1 protein results in intense expression in human breast cancer tissue as measured by liquid chromatography-isotope-dilution tandem mass spectrometry.
Coskun E; Jaruga P; Jemth AS; Loseva O; Scanlan LD; Tona A; Lowenthal MS; Helleday T; Dizdaroglu M
DNA Repair (Amst); 2015 Sep; 33():101-10. PubMed ID: 26202347
[TBL] [Abstract][Full Text] [Related]
2. Identification and quantification of human DNA repair protein NEIL1 by liquid chromatography/isotope-dilution tandem mass spectrometry.
Reddy PT; Jaruga P; Kirkali G; Tuna G; Nelson BC; Dizdaroglu M
J Proteome Res; 2013 Feb; 12(2):1049-61. PubMed ID: 23268652
[TBL] [Abstract][Full Text] [Related]
3. Identification and quantification of DNA repair proteins by liquid chromatography/isotope-dilution tandem mass spectrometry using their fully 15N-labeled analogues as internal standards.
Dizdaroglu M; Reddy PT; Jaruga P
J Proteome Res; 2011 Aug; 10(8):3802-13. PubMed ID: 21619077
[TBL] [Abstract][Full Text] [Related]
4. Extreme Expression of DNA Repair Protein Apurinic/Apyrimidinic Endonuclease 1 (APE1) in Human Breast Cancer As Measured by Liquid Chromatography and Isotope Dilution Tandem Mass Spectrometry.
Coskun E; Jaruga P; Reddy PT; Dizdaroglu M
Biochemistry; 2015 Sep; 54(38):5787-90. PubMed ID: 26359670
[TBL] [Abstract][Full Text] [Related]
5. MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool.
Gad H; Koolmeister T; Jemth AS; Eshtad S; Jacques SA; Ström CE; Svensson LM; Schultz N; Lundbäck T; Einarsdottir BO; Saleh A; Göktürk C; Baranczewski P; Svensson R; Berntsson RP; Gustafsson R; Strömberg K; Sanjiv K; Jacques-Cordonnier MC; Desroses M; Gustavsson AL; Olofsson R; Johansson F; Homan EJ; Loseva O; Bräutigam L; Johansson L; Höglund A; Hagenkort A; Pham T; Altun M; Gaugaz FZ; Vikingsson S; Evers B; Henriksson M; Vallin KS; Wallner OA; Hammarström LG; Wiita E; Almlöf I; Kalderén C; Axelsson H; Djureinovic T; Puigvert JC; Häggblad M; Jeppsson F; Martens U; Lundin C; Lundgren B; Granelli I; Jensen AJ; Artursson P; Nilsson JA; Stenmark P; Scobie M; Berglund UW; Helleday T
Nature; 2014 Apr; 508(7495):215-21. PubMed ID: 24695224
[TBL] [Abstract][Full Text] [Related]
6. Identification and quantification of DNA repair protein poly(ADP ribose) polymerase 1 (PARP1) in human tissues and cultured cells by liquid chromatography/isotope-dilution tandem mass spectrometry.
Coskun E; Tuna G; Jaruga P; Tona A; Erdem O; Dizdaroglu M
DNA Repair (Amst); 2019 Mar; 75():48-59. PubMed ID: 30743082
[TBL] [Abstract][Full Text] [Related]
7. Comparison of liquid chromatography-tandem mass spectrometry-based targeted proteomics and conventional analytical methods for the determination of P-glycoprotein in human breast cancer cells.
Yang T; Xu F; Xu J; Fang D; Yu Y; Chen Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 936():18-24. PubMed ID: 23968647
[TBL] [Abstract][Full Text] [Related]
8. Association of MTH1 expression with the tumor malignant potential and poor prognosis in patients with resected lung cancer.
Fujishita T; Okamoto T; Akamine T; Takamori S; Takada K; Katsura M; Toyokawa G; Shoji F; Shimokawa M; Oda Y; Nakabeppu Y; Maehara Y
Lung Cancer; 2017 Jul; 109():52-57. PubMed ID: 28577950
[TBL] [Abstract][Full Text] [Related]
9. Structure of human MTH1, a Nudix family hydrolase that selectively degrades oxidized purine nucleoside triphosphates.
Mishima M; Sakai Y; Itoh N; Kamiya H; Furuichi M; Takahashi M; Yamagata Y; Iwai S; Nakabeppu Y; Shirakawa M
J Biol Chem; 2004 Aug; 279(32):33806-15. PubMed ID: 15133035
[TBL] [Abstract][Full Text] [Related]
10. Identification and quantification of DNA repair protein apurinic/apyrimidinic endonuclease 1 (APE1) in human cells by liquid chromatography/isotope-dilution tandem mass spectrometry.
Kirkali G; Jaruga P; Reddy PT; Tona A; Nelson BC; Li M; Wilson DM; Dizdaroglu M
PLoS One; 2013; 8(7):e69894. PubMed ID: 23922845
[TBL] [Abstract][Full Text] [Related]
11. A Chimeric ATP-Linked Nucleotide Enables Luminescence Signaling of Damage Surveillance by MTH1, a Cancer Target.
Ji D; Beharry AA; Ford JM; Kool ET
J Am Chem Soc; 2016 Jul; 138(29):9005-8. PubMed ID: 27413803
[TBL] [Abstract][Full Text] [Related]
12. MutT homologue 1 (MTH1) removes N6-methyl-dATP from the dNTP pool.
Scaletti ER; Vallin KS; Bräutigam L; Sarno A; Warpman Berglund U; Helleday T; Stenmark P; Jemth AS
J Biol Chem; 2020 Apr; 295(15):4761-4772. PubMed ID: 32144205
[TBL] [Abstract][Full Text] [Related]
13. Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue.
McPherson LA; Troccoli CI; Ji D; Bowles AE; Gardiner ML; Mohsen MG; Nagathihalli NS; Nguyen DM; Robbins DJ; Merchant NB; Kool ET; Rai P; Ford JM
DNA Repair (Amst); 2019 Nov; 83():102644. PubMed ID: 31311767
[TBL] [Abstract][Full Text] [Related]
14. A liquid chromatography-tandem mass spectrometry-based targeted proteomics approach for the assessment of transferrin receptor levels in breast cancer.
Yang T; Xu F; Zhao Y; Wang S; Yang M; Chen Y
Proteomics Clin Appl; 2014 Oct; 8(9-10):773-82. PubMed ID: 24659461
[TBL] [Abstract][Full Text] [Related]
15. Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy.
Huber KV; Salah E; Radic B; Gridling M; Elkins JM; Stukalov A; Jemth AS; Göktürk C; Sanjiv K; Strömberg K; Pham T; Berglund UW; Colinge J; Bennett KL; Loizou JI; Helleday T; Knapp S; Superti-Furga G
Nature; 2014 Apr; 508(7495):222-7. PubMed ID: 24695225
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a stable isotope labeled (SIL) peptide and an extended SIL peptide as internal standards to track digestion variability of an unstable signature peptide during quantification of a cancer biomarker, human osteopontin, from plasma using capillary microflow LC-MS/MS.
Faria M; Halquist MS; Yuan M; Mylott W; Jenkins RG; Karnes HT
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():156-68. PubMed ID: 26279007
[TBL] [Abstract][Full Text] [Related]
17. Potent and specific MTH1 inhibitors targeting gastric cancer.
Zhou W; Ma L; Yang J; Qiao H; Li L; Guo Q; Ma J; Zhao L; Wang J; Jiang G; Wan X; Adam Goscinski M; Ding L; Zheng Y; Li W; Liu H; Suo Z; Zhao W
Cell Death Dis; 2019 Jun; 10(6):434. PubMed ID: 31164636
[TBL] [Abstract][Full Text] [Related]
18. Validation and development of MTH1 inhibitors for treatment of cancer.
Warpman Berglund U; Sanjiv K; Gad H; Kalderén C; Koolmeister T; Pham T; Gokturk C; Jafari R; Maddalo G; Seashore-Ludlow B; Chernobrovkin A; Manoilov A; Pateras IS; Rasti A; Jemth AS; Almlöf I; Loseva O; Visnes T; Einarsdottir BO; Gaugaz FZ; Saleh A; Platzack B; Wallner OA; Vallin KS; Henriksson M; Wakchaure P; Borhade S; Herr P; Kallberg Y; Baranczewski P; Homan EJ; Wiita E; Nagpal V; Meijer T; Schipper N; Rudd SG; Bräutigam L; Lindqvist A; Filppula A; Lee TC; Artursson P; Nilsson JA; Gorgoulis VG; Lehtiö J; Zubarev RA; Scobie M; Helleday T
Ann Oncol; 2016 Dec; 27(12):2275-2283. PubMed ID: 27827301
[TBL] [Abstract][Full Text] [Related]
19. Investigation of MTH1 activity via mismatch-based DNA chain elongation.
Gao T; Gu S; Liu F; Li L; Wang Z; Yang J; Li G
Anal Chim Acta; 2016 Jan; 905():66-71. PubMed ID: 26755138
[TBL] [Abstract][Full Text] [Related]
20. Cellular 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate pyrophosphohydrolase activity of human and mouse MTH1 proteins does not depend on the proliferation rate.
Bialkowski K; Kasprzak KS
Free Radic Biol Med; 2004 Nov; 37(10):1534-41. PubMed ID: 15477005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
